Showing results (211-220 of 241) with videos related to

Sort By:
Pageof 25
Gynecologic Oncology|April 11, 2017
Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocolWilliam T Creasman, Shamshad Ali, David G Mutch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group StudyD Scott McMeekin, David L Tritchler, David E Cohn, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Targeting RAD52 overcomes PARP inhibitor resistance in preclinical Brca2-deficient ovarian cancer modelYukihide Ota, Vijayalaxmi Gupta, Bisiayo E Fashemi, et al.
Molecular Cancer Research : MCR|August 1, 2023
Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix ProteinsAngela M Schab, Molly M Greenwade, Elizabeth Stock, et al.
International Journal of Radiation Oncology, Biology, Physics|January 23, 2026
Phase I Clinical Trial of De-escalated Conformal Radiation Expedited Sequentially with Chemotherapy for Advanced Endometrial Cancer (DeCRESCEndo)Joshua P Schiff, Silpa Raju-Salicki, Tyler R McKinnish, et al.
Gynecologic Oncology|November 15, 2017
An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancerCasey M Cosgrove, David L Tritchler, David E Cohn, et al.
Pageof 25